Kazia Therapeutics (KZIA) Interest & Investment Income (2021 - 2024)

Kazia Therapeutics' (KZIA) quarterly Interest & Investment Income came in at $256370.5 in Q2 2010.

Analysis

Kazia Therapeutics (KZIA) Interest & Investment Income (2021 - 2024) Analysis & Trends

Kazia Therapeutics (KZIA) has 1 years of Interest & Investment Income data on file, last reported at $256370.5 in Q2 2010.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	120.60 Mn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	-48.00 Mn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	48.00 Mn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	67.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	35.58 Mn
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	27.90 Mn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	28.14 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	5.13 Mn
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	10.98 Mn
10	Kazia Therapeutics	91.11 Mn	91.11 Mn	-	-

Historic Data

Download Data